Top

Open Access 13-01-2025 | Type 1 Diabetes | Review

Young Adults with Type 1 Diabetes’ Clinical Outcomes and Satisfaction Related to the Use of Videoconferencing for Type 1 Diabetes Healthcare: A Narrative Review

Authors: Steven James, Mahira Saiyed, Olive James, Rutul Gokalani, Megan Paterson, Kiran Mejia Mehta, Emma Klatman, Judy Craft, Roopa Mehta

Published in: Diabetes Therapy

Abstract

Introduction

Young adulthood is well documented as being a particularly challenging area of type 1 diabetes (T1D) healthcare. Many young adults with T1D (YAT1D) are distracted from effective disease self-management; T1D healthcare service engagement can be problematic and inconsistent, and high rates of unplanned healthcare contacts prevail. Video conferencing use can facilitate services to be flexible and responsive. We aimed to evaluate clinical outcomes and satisfaction related to the use of videoconferencing for T1D healthcare in YAT1D.

Methods

A quantitative narrative review was undertaken, using a systematic process. PubMed, Scopus and CINAHL were searched (until August 2023) to identify relevant articles, using Medical Subject Headings and keywords. A total of 12 records (eight studies) from four countries were retrieved.

Results

Ten records considered clinical outcomes; eight of these records focused on the effectiveness of videoconferencing as part of routine care. Findings largely demonstrate benefits to glycaemic control, particularly when used during the COVID-19 pandemic; no data were available relating to the impact of videoconferencing use on blood pressure and lipid control in YAT1D. Four records considered satisfaction with use of videoconferencing, with data indicating YAT1D were satisfied with the use of videoconferencing technology.

Conclusions

There is a need to configure T1D healthcare services to incorporate and offer use of videoconferencing technology, where applicable, appropriate and acceptable for YAT1D, and feasible and workable for service providers. This will require some adjustments from healthcare systems and possible changes to funding mechanisms.

Available only for authorised users

Type 1 diabetes Index Group. About the T1D index; 2024. https://www.t1dindex.org/about/. Accessed 18 Nov 2024.

Sun H, Saeedi P, Karuranga S, et al. IDF diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183:109119.CrossRefPubMed

International Diabetes Federation. IDF diabetes atlas, 10th edn. International Diabetes Federation, Brussels; 2021. https://diabetesatlas.org/. Accessed 24 Dec 2023.

Arnett J. Emerging adulthood: the winding road from the late teens through the twenties. New York: Oxford University Press; 2004.

James S, Perry L, Gallagher R, Lowe J. A discussion of healthcare support for adolescents and young adults with long-term conditions: current policy and practice and future opportunities. Int J Nursing Pract. 2020;26(5):12882. https://doi.org/10.1111/ijn.12882.CrossRef

James S, Perry L, Lowe J, et al. Suboptimal glycemic control in adolescents and young adults with type 1 diabetes from 2011 to 2020 across Australia and New Zealand: data from the Australasian Diabetes Data Network registry. Pediatr Diabetes. 2022;23(6):736–41. https://doi.org/10.1111/pedi.13364.CrossRefPubMed

James S, Perry L, Lowe J, et al. Blood pressure in adolescents and young adults with type 1 diabetes: data from the Australasian Diabetes Data Network registry. Acta Diabetol. 2023;60(6):797–803.CrossRefPubMedPubMedCentral

James S, Donaghue KC, Perry L, Lowe J, Colman PG, Craig ME. Low-density lipoprotein cholesterol in adolescents and young adults with type 1 diabetes: data from the Australasian Diabetes Data Network registry. Diabet Med. 2023;40(11):e15184. https://doi.org/10.1111/dme.15184.CrossRefPubMed

James S, Perry L, Gallagher R, et al. Service usage and vascular complications in young adults with type 1 diabetes. BMC Endocr Disord. 2014;14(39):1–9. https://doi.org/10.1186/1472-6823-14-39.CrossRef

10.

American Diabetes Association. Diabetes care for emerging adults: recommendations for transition from pediatric to adult diabetes care systems. Diabetes Care. 2011;34:2477–85. https://doi.org/10.2337/dc11-1723.CrossRef

11.

Hynes L, Byrne M, Dineen SF, McGuire BE, O'Donnell, M, McSharry J. Barriers and facilitators associated with attendance at hospital diabetes clinics among young adults (15–30 years) with type 1 diabetes mellitus: a systematic review. Pediatr Diabetes. 2014;17(7):509–18. https://doi.org/10.1111/pedi.12198.CrossRefPubMed

12.

James S, Gallagher R, Dunbabin J, Perry L. Prevalence of vascular complications and factors predictive of their development in young adults with type 1 diabetes: systematic literature review. BMC Res Notes. 2014;7(593):1–11. https://doi.org/10.1186/1756-0500-7-593.CrossRef

13.

Perry L, Dunbabin J, Xu X, et al. Service use of young people with type 1 diabetes after transition from paediatric to adult-based diabetes health care. Aust Health Rev. 2020;44(4):601–8.CrossRefPubMed

14.

Perry L, James S, Steinbeck K, Dunbabin J, Lowe J. Young people with type 1 diabetes: attitudes, perceptions and experiences of diabetes management and continuous subcutaneous insulin infusion therapy. J Eval Clin Pract. 2017;23(3):554–61.CrossRefPubMed

15.

Cristello Sarteau A, Peerzada A, Goyal A, Praveen PA, Tandon N. Development and design of the first structured clinic-based program in lower resource settings to transition emerging adults with type 1 diabetes from pediatric to adult care. PLOS Glob Public Health. 2022;2(8):e0000665. https://doi.org/10.1371/journal.pgph.0000665.CrossRefPubMedPubMedCentral

16.

Spaic T, Robinson T, Goldbloom E, et al. Closing the gap: results of the multicenter Canadian randomized controlled trial of structured transition in young adults with type 1 diabetes. Diabetes Care. 2019;42(6):1018.CrossRefPubMed

17.

Pomerantz J, Brooks D. ECAR study of undergraduate students and information technology, EDUCAUSE center for analysis and research. Research report. Louisville: ECAR; 2017.

18.

Dunbabin J, Perry L, Steinbeck K, Haas M, James S, Lowe J. Can telehealth engage young people with type 1 diabetes? Experiences from the YOuR-Diabetes project. Aust Diabetes Educ. 2015;18(3):32–34j.

19.

Verhoeven F, van Gemert-Pijnen L, Dijkstra K, Mijland N, Seydel E, Steehouder M. The contribution of teleconsultation and videoconferencing to diabetes care: a systematic literature review. J Med Internet Res. 2007;9(5):e37. https://doi.org/10.2196/jmir.9.5.e37.CrossRefPubMedPubMedCentral

20.

Centre for Reviews and Dissemination. Systematic reviews. CRD's guidance for undertaling reviews in health care; 2009. https://www.york.ac.uk/crd/SysRev/!SSL!/WebHelp/SysRev3.htm. Accessed 18 Sept 2023.

21.

PRISMA. PRISMA checklist; 2020. http://prisma-statement.org/prismastatement/checklist.aspx?AspxAutoDetectCookieSupport=1. Accessed 18 Sept 2023.

22.

Ferrari R. Writing narrative style literature reviews. Med Writing (Leeds). 2015;24:230–5. https://doi.org/10.1179/2047480615Z.000000000329.CrossRef

23.

Albanese-O’Neill A, Beauchamp G, Thomas N, et al. Transition education for young adults with type 1 diabetes: pilot feasibility study for a group telehealth intervention. JMIR Diabetes. 2018;3(4):e10909.CrossRefPubMedPubMedCentral

24.

Bassi M, Strati MF, Parodi S, et al. Patient satisfaction of telemedicine in pediatric and young adult type 1 diabetes patients during covid-19 pandemic. Front Public Health. 2022;10:857561.CrossRefPubMedPubMedCentral

25.

Bisno D, Reid MW, Fogel JL, Pyatak EA, Majidi S, Raymond JK. Virtual group appointments reduce distress and improve care management in young adults with type 1 diabetes. J Diabetes Sci Technol. 2022;16(6):1419–27.CrossRefPubMed

26.

Duke D, Wagner DV, Ulrich J, Freeman KA, Harris MA. Videoconferencing for teens with diabetes: family matters. J Diabetes Sci Technol. 2016;10(4):816–23.CrossRefPubMedPubMedCentral

27.

Garcia J, Faye E, Reid MW, et al. Greater telehealth use results in increased visit frequency and lower physician related-distress in adolescents and young adults with type 1 diabetes. J Diabetes Sci Technol. 2023;17(4):878–86.CrossRefPubMed

28.

Harris M, Freeman K, Duke D. Seeing is believing: using skype to improve diabetes outcomes in youth. Diabetes Care. 2015;38(8):1427–34.CrossRefPubMed

29.

Lazzeroni P, Motta M, Monaco S, et al. Improvement in glycaemic control in paediatric and young adult type 1 diabetes patients during COVID-19 pandemic: role of telemedicine and lifestyle changes. Acta Biomed. 2021;92(5):e2021399.PubMedPubMedCentral

30.

Rachmiel M, Lebenthal Y, Mazor-Aronovich K, et al. Glycaemic control in the paediatric and young adult population with type 1 diabetes following a single telehealth visit—what have we learned from the COVID-19 lockdown? Acta Diabetol. 2021;58(6):697–705.CrossRefPubMedPubMedCentral

31.

Raymond J, Berget CL, Driscoll KA, Kethcum, K, Cain C, Fred Thomas, JF. CoYoT1 clinic: innovative telemedicine care model for young adults with type 1 diabetes. Diabetes Technol Ther. 2016;18(6):385–90.CrossRefPubMedPubMedCentral

32.

Reid M, Krishna S, Berget C, et al. CoYoT1 clinic: home telemedicine increases young adult engagement in diabetes care. Diabetes Technol Ther. 2018;20(5):370–9.CrossRefPubMed

33.

Salabelle C, Ly Sall K, Eroukhmanoff J, et al. COVID-19 pandemic lockdown in young people with type 1 diabetes: positive results of an unprecedented challenge for patients through telemedicine and change in use of continuous glucose monitoring. Prim Care Diabetes. 2021;15(5):884–6.CrossRefPubMedPubMedCentral

34.

Wan W, Nathan AG, Skandari MR, et al. Cost-effectiveness of shared telemedicine appointments in young adults with T1D: CoYoT1 trial. Diabetes Care. 2019;42(8):1589–92.CrossRefPubMedPubMedCentral

35.

Garcia F, Faye E, Reid M. Corrigendum to “Greater telehealth use results in increased visit frequency and lower physician related-distress in adolescents and young adults with type 1 diabetes”. J Diabetes Sci Technol. 2023;17(4):1134–5.CrossRef

36.

Nakhla M, Nakhla M, Daneman D, To T, Paradis G, Gutmann A. Transition to adult care for youths with diabetes mellitus: findings from a universal health care system. Pediatrics. 2009;124:e1134–41.CrossRefPubMed

37.

Wang X, Shu W, Du J, et al. Mobile health in the management of type 1 diabetes: a systematic review and meta-analysis. BMC Endocr Disord. 2019;19(21):1–10.

38.

Farrell K, Fernandez R, Salamonson Y, Griffiths R, Holmes-Walker DJ. Health outcomes for youth with type 1 diabetes at 18 months and 30 months post transition from pediatric to adult care. Diabetes Res Clin Pract. 2018;139:163–9.CrossRefPubMed

39.

Patton G, Sawyer SM, Santelli JS, et al. Our future: a Lancet Commission on adolescent health and wellbeing. Lancet. 2016;387(10036):2423–78. https://doi.org/10.1016/S0140-6736(16)00579-1.CrossRefPubMedPubMedCentral

40.

United Nations Human Rights. CHR call for submissions on its General Comment on the rights of adolescents; 2019. http://www.ohchr.org/EN/HRBodies/CRC/Pages/CallRightsofAdolescents.aspx, Accessed 10 Jun 2019.

41.

Birch J, Pang D, Alston RD, et al. Survival from cancer in teenagers and young adults in England 1979–2003. Brit J Cancer. 2008;99:830–55.CrossRefPubMedPubMedCentral

42.

Kibbey K, Speight J, Wong LA, Smith LA, Teed HJ. Diabetes care provision: barriers, enablers and service needs of young adults with type 1 diabetes from a region of social disadvantage. Diabet Med. 2013;30:878–84. https://doi.org/10.1111/dme.12227.CrossRefPubMed

43.

Ng A, Crowe TC, Ball K, Rasmussen, B. Transitional needs of Australian young adults with type 1 diabetes: mixed methods study. JMIR Diabetes. 2017;2(2):e29. https://doi.org/10.2196/diabetes.8315.CrossRefPubMedPubMedCentral

44.

James S. Current and future services to support young adults with type 1 diabetes in Australia; 2017. https://opus.lib.uts.edu.au/handle/10453/120181. Accessed 17 Jun 2021.

45.

Bakhach M, Reid MW, Pyatak EA, et al. Home telemedicine (CoYoT1 Clinic): a novel approach to improve psychosocial outcomes in young adults with diabetes. Diabetes Educ. 2019;45(4):420–30.CrossRefPubMed

46.

Gregory G, Robinson TIG, Linklater SE, et al. Global incidence, prevalence, and mortality of type 1 diabetes in 2021 with projection to 2040: a modelling study. Lancet Diabetes Endocrinol. 2022;10(10):741–60. https://doi.org/10.1016/S2213-8587(22)00218-2.CrossRefPubMed

47.

Sanal G, Shijin S, Krishna V, et al. Empowering patients with type 1 diabetes through a multidisciplinary team-assisted, technology-enabled education program. Curr Diabetes Rev. 2023;19(4):e200522205073.CrossRefPubMed

Title: Young Adults with Type 1 Diabetes’ Clinical Outcomes and Satisfaction Related to the Use of Videoconferencing for Type 1 Diabetes Healthcare: A Narrative Review
Authors: Steven James
Mahira Saiyed
Olive James
Rutul Gokalani
Megan Paterson
Kiran Mejia Mehta
Emma Klatman
Judy Craft
Roopa Mehta
Publication date: 13-01-2025
Publisher: Springer Healthcare
Keywords: Type 1 Diabetes
Telemedicine
Digital Health
Endocrinology
Published in: Diabetes Therapy
Print ISSN: 1869-6953
Electronic ISSN: 1869-6961
DOI: https://doi.org/10.1007/s13300-024-01688-2

At a glance: The STEP trials

Obesity
Clinical Trial Summary

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine